Article

A study protocol to prepare an RBD protein for vaccine against COVID-19

2022-09-29

Abstract excerpt

<h4>Background: </h4> SARS-CoV-2 pandemic is a global threat to humans and the world’s economy. Effective and safe vaccines against this virus are essential to control and eradicate the pandemic. The currently applied vaccines carry SARS-CoV-2 spike-protein mRNA/cDNA. These vaccines go through several cellular processes in the recipients for producing antigens. On the contrary, the SARS-CoV-2 RBD (receptor bindin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b5be6393-8f0f-5981-985e-94aceeaf7743
DOI: 10.12688/f1000research.54738.3

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A study protocol to prepare an RBD protein for vaccine against COVID-19DOI 10.12688/f1000research.54738.3Read

Yeast-expressed Recombinant SARS-CoV-2 Receptor Binding Domain, RBD203-N1 as a COVID-19 Protein Vaccine CandidateSemantic proximity Read

Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2Semantic proximity Read

A Potential Novel COVID-19 Vaccine With RBD-HR1/HR2 Hexamer StructureSemantic proximity Read

Scale-up Production and Immunological Assessment of Recombinant SARS- CoV-2 Spike RBD in Pichia pastorisSemantic proximity Read

Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants.Semantic proximity Read

Development of an ancestral DC and TLR4-inducing multi-epitope peptide vaccine against the spike protein of SARS-CoV and SARS-CoV-2 using the advanced immunoinformatics approachesSemantic proximity Read

Immune response to vaccine candidates based on different types of nanoscaffolded RBD domain of the SARS-CoV-2 spike proteinSemantic proximity Read

A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation.Semantic proximity Read

Development of an RBD-Fc fusion vaccine for COVID-19Semantic proximity Read

Development of an in vitro method to assess the immunogenicity of biologics in the prevention of infectious diseasesSemantic proximity Read

Enhancing the Immunogenicity of RBD Protein Variants through Amino Acid E484 Mutation in SARS-CoV-2.Semantic proximity Read

An Efficient Approach for SARS-CoV-2 Monoclonal Antibody Production via Modified mRNA-LNP ImmunizationSemantic proximity Read